OTC FILING WATCH · LIVEOfficial-source OTC filing intelligence
ISSUER DOSSIER · CIK 0002102720

Tarsier Pharma Ltd.

Issuer profile4 captured filing nodes

Business context

Official SEC registration filing — F-1/A. Read the linked SEC filing for business, risk factors and offering details.

First captured2026-05-18
Latest filingF-1/A · 2026-07-16
Registration path0 initial filings · 4 amendments

What to watch next

Compare the next amendment against the current filing, then monitor for EFFECT or 424B. Material offering terms can change between amendments.

Latest captured filing: F-1/A · 2026-07-16 · 14 days ago.

PUBLIC-RECORD DILIGENCE

Need a documented diligence trail?

Use this issuer dossier as the starting evidence layer. A defined scope can package the official filing history, public company actions and questions for your independently retained advisers to review.

Request diligence scope →Read shell diligence checklist

Official filing timeline

  1. F-1/A · official filing

    Tarsier Pharma Ltd.

  2. F-1/A · official filing

    Tarsier Pharma Ltd.

  3. F-1/A · official filing

    Tarsier Pharma Ltd. (TARX)

  4. F-1/A · official filing

    Tarsier Pharma Ltd. (TARX)

Open latest official filing →